Alembic receives USFDA final approval for Ticagrelor Tablets, 90 mg and tentative approval for Ticagrelor Tablets, 60 mg
Ticagrelor tablets are indicated for to reduce the risk of cardiovascular death and myocardial infarction,
Ticagrelor tablets are indicated for to reduce the risk of cardiovascular death and myocardial infarction,
Priced at just Rs. 499 for 1-year supply, this initiative is aligned with the vision of Health for All
This Product is indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension
Investment demonstrates confidence in America’s commitment to science and innovation
The positive opinions are based on applications submitted by Biosimilar Collaborations Ireland Limited
The company has received final approval from the Department of Pharmaceuticals, Government of India, for foreign investment under applicable regulations
Ami Organics’ Ankleshwar Unit II gets GMP compliant by PMDA Japan
Akums and TNAU will collaborate to strengthen research through shared expertise and innovative agricultural solutions, to foster innovation in formulation development
Tolvaptan is indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease
Phytonadione Injectable Emulsion possesses the same type and degree of activity as does naturally-occurring vitamin K
Subscribe To Our Newsletter & Stay Updated